Prognostic Performance of Inflammatory Biomarkers Based on Complete Blood Counts in COVID-19 Patients.

With the end of the pandemic, COVID-19 has entered an endemic phase with expected seasonal spikes. Consequently, the implementation of easily accessible prognostic biomarkers for patients with COVID-19 remains an important area of research. In this monocentric study at a German tertiary care hospital, we determined the prognostic performance of different clinical and blood-based parameters in 412 COVID-19 patients.

SARS-CoV-2 spike protein is present in both endothelial and eccrine cells of a chilblain-like skin lesion.

Data on SARS‐CoV‐2 detection in lesional skin is controversial. We report a PCR‐proven COVID‐19 patient with a chilblain‐like SARS‐CoV‐2 positive skin lesion. An 80‐year‐old woman presented to the emergency department at the End of March 2020.